Revenue-stage company selling the world’s first brain monitor for point-of-care seizure triage and treatment optimization.
Ceribell
Neurology
Total Addressable Market
Red Tree Board Member(s)
Red Tree Board Observer
Heath Lukatch, Ph.D.
Red Tree Participation
Co-investor in Series C and Series D
